Skip to main content
SpringerLink
Log in

Limited Sampling Strategies

  • Correspondence
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gaspari F, Anedda MF, Signorini O, et al. Prediction of cylosporine area under the curve using a three-point sampling strategy after Neoral administration. J Am Soc Nephrol 1998; 8: 647–52.

    Google Scholar 

  2. Foradori AC, Martinez L, Elberg A, et al. Prliminary pharmacokinetic evalutation of a new galenical formulation of oral cyclosporine A: Neoral™. Transplant Proc 1995; 27: 1813–4.

    PubMed  CAS  Google Scholar 

  3. Serafinowicz A, Gaciong Z, Baczkowska T, et al. Limited sampling strategy to estimate exposure to CsA in renal allograft recipients (RARs) treated with Sandimmune-Neoral (NEO) [abstract]. Second International Conference on New Trends in Clinical and Experimental Immunosuppression; 1996 Feb 15–18; Geneva, Switzerland, 59.

    Google Scholar 

  4. Kahan BD, Dunn J, Fitts C, et al. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals. Transplantation 1995; 59: 505–11.

    PubMed  CAS  Google Scholar 

  5. The Canadian Neoral Study Group. A randomized, prospective multicentre pharmacoepidemiologic study of Neoral (cyclosporine microemulsion) in stable renal graft recipients [abstract]. American Society of Transplant Physicians 15th Annual Meeting; 1996 May 26–30; Dallas (TX), 170.

    Google Scholar 

  6. Amante A, Lindholm A, Welsh M, et al. Cyclosporine pharmacokinetic risk factors for acute rejection episodes in renal transplantation [abstract]. American Society of Transplant Physicians 15th Annual Meeting; 1996 May 26–30; Dallas (TX), 224.

    Google Scholar 

  7. Gaspari F, Perico N, Signorini O, et al. Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Kidney Int 1998; 54: 2146–50.

    Article  PubMed  CAS  Google Scholar 

  8. Amante AJ, Kahan BD. Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant period. Transplant Proc 1996; 28: 2162–3.

    PubMed  CAS  Google Scholar 

  9. Keown P, Landsberg D, Halloran P, et al. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients: report of the Canadian Neoral Transplantation Study Group. Transplantation 1996; 62: 1744–52.

    Article  PubMed  CAS  Google Scholar 

  10. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981; 9: 503–12.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada

    Randall J. Dumont & Mary H. H. Ensom

Authors
  1. Randall J. Dumont
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary H. H. Ensom
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dumont, R.J., Ensom, M.H.H. Limited Sampling Strategies. Clin Pharmacokinet 39, 311–312 (2000). https://doi.org/10.2165/00003088-200039040-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-200039040-00007

Keywords

Search

Navigation